Skip to main content
Year archive

KANGSTEM BIOTECH CO., LTD. — 2020 filings

All 31 regulatory filings released by KANGSTEM BIOTECH CO., LTD. (217730) in 2020, sourced directly from the official regulator.

31 Filings
2020 Period
2020 filings (31)
Filing Released Lang
[기재정정]투자판단관련주요경영사항(제대혈 유래 줄기세포 아토피피부염 치료제 국내 독점판권/통상실시권 설정 및 기술전수 계약 체결)
Management Reports
2020-12-10 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-10 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-11-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-11-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-11-09 Korean
투자판단관련주요경영사항(중등도 이상의 만성 아토피피부염 환자를 대상으로 퓨어스템-에이디주(FURESTEM-AD Inj.)의 제3상 임상시험 신청)
Regulatory Filings
2020-10-29 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2020-10-14 Korean
기타경영사항(특허권취득)(자율공시)(PI3K/AKT/GSK3 경로를 통해 성체줄기세포의 증식, 다분화능 및 재프로그래밍을 촉진하는 CD49f)
Regulatory Filings
2020-08-26 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-06-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-06-09 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-14 Korean
사업보고서 (2019.12)
Audit Report / Information FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-25 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-17 Korean
기타경영사항(특허권취득)(자율공시)(HMGA2를 이용하여 비신경 세포로부터 리프로그래밍 된)
Regulatory Filings
2020-03-17 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-03-10 Korean
주주총회집중일개최사유신고
Regulatory Filings
2020-03-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-03-10 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제1회차)
Capital/Financing Update
2020-03-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-02-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-02-18 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-01-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-01-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-01-07 Korean